Why is Aarti Drugs falling/rising?

As of 04-Jul, Aarti Drugs Ltd's stock price is currently at 487.55, reflecting an increase of 3.7 (0.76%). The stock has been on an upward trend, gaining for the last six days and achieving a total return of 9.45% during this period. It has outperformed its sector by 0.25% today and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite a year-over-year decline of 9.01%, the company has shown strong financial metrics, including a high return on capital employed (ROCE) of 17.84% and significant growth in profit before tax and profit after tax in the latest quarter. However, there are concerns regarding long-term growth, as net sales and operating profit have only grown at 5.74% and 1.65% annually over the last five years, respectively.
In the broader market context, Aarti Drugs has outperformed the Sensex in the short term, with a 1-week return of 7.65% compared to the benchmark's decline of 0.74%. While the stock has seen increased participation from institutional investors, who have raised their stake by 0.9%, it has consistently underperformed against the benchmark over the last three years. This mixed performance indicates that while there are positive short-term movements and institutional interest, the long-term outlook remains uncertain due to historical underperformance and modest growth rates.